Similarly, the present study demonstrated a significantly increased hepatic MCP-1 expression in the HFD group compared with those in the NC group, further indicating the progression of hepatic steatosis towards NASH and fibrosis, as well as the increased inability of the liver to manage fat infiltration. Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.